» Articles » PMID: 17848192

Staphylococcus Aureus Intestinal Colonization is Associated with Increased Frequency of S. Aureus on Skin of Hospitalized Patients

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2007 Sep 13
PMID 17848192
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intestinal colonization by Staphylococcus aureus among hospitalized patients has been associated with increased risk of staphylococcal infection and could potentially contribute to transmission. We hypothesized that S. aureus intestinal colonization is associated with increased frequency of S. aureus on patients' skin and nearby environmental surfaces.

Methods: Selected inpatients were cultured weekly for S. aureus from stool, nares, skin (groin and axilla), and environmental surfaces (bed rail and bedside table). Investigator's hands were cultured after contacting the patients' skin and the environmental surfaces.

Results: Of 71 subjects, 32 (45.1%) had negative nares and stool cultures, 23 (32.4%) had positive nares and stool cultures, 13 (18.3%) were nares carriers only, and 3 (4.2%) were stool carriers only. Of the 39 patients with S. aureus carriage, 30 (76.9%) had methicillin-resistant isolates. In comparison to nares colonization only, nares and intestinal colonization was associated with increased frequency of positive skin cultures (41% versus 77%; p = 0.001) and trends toward increased environmental contamination (45% versus 62%; p = 0.188) and acquisition on investigator's hands (36% versus 60%; p = 0.057). Patients with negative nares and stool cultures had low frequency of S. aureus on skin and the environment (4.8% and 11.3%, respectively).

Conclusion: We found that hospitalized patients with S. aureus nares and/or stool carriage frequently had S. aureus on their skin and on nearby environmental surfaces. S. aureus intestinal colonization was associated with increased frequency of positive skin cultures, which could potentially facilitate staphylococcal infections and nosocomial transmission.

Citing Articles

Multimodal analysis identifies microbiome changes linked to stem cell transplantation-associated diseases.

Artacho A, Gonzalez-Torres C, Gomez-Cebrian N, Moles-Poveda P, Pons J, Jimenez N Microbiome. 2024; 12(1):229.

PMID: 39511587 PMC: 11542268. DOI: 10.1186/s40168-024-01948-0.


Hand and environmental hygiene: respective roles for MRSA, multi-resistant gram negatives, Clostridioides difficile, and Candida spp.

Boyce J Antimicrob Resist Infect Control. 2024; 13(1):110.

PMID: 39334403 PMC: 11437781. DOI: 10.1186/s13756-024-01461-x.


IL-10 inhibition during immunization improves vaccine-induced protection against Staphylococcus aureus infection.

Kelly A, McCarthy K, Claxton T, Carlile S, OBrien E, Vozza E JCI Insight. 2024; 9(13).

PMID: 38973612 PMC: 11383370. DOI: 10.1172/jci.insight.178216.


Staphylococcus aureus colonisation and strategies for decolonisation.

Piewngam P, Otto M Lancet Microbe. 2024; 5(6):e606-e618.

PMID: 38518792 PMC: 11162333. DOI: 10.1016/S2666-5247(24)00040-5.


Impact of active surveillance and decolonization strategies for methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit.

Gollerkeri S, Oliver C, Maria M, Green D, Wu F, Paul A J Perinatol. 2024; 44(5):724-730.

PMID: 38351274 DOI: 10.1038/s41372-024-01902-w.


References
1.
Gravet A, Rondeau M, Harf-Monteil C, Grunenberger F, Monteil H, Scheftel J . Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. J Clin Microbiol. 1999; 37(12):4012-9. PMC: 85868. DOI: 10.1128/JCM.37.12.4012-4019.1999. View

2.
Boyce J, Havill N, Maria B . Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2005; 43(12):5992-5. PMC: 1317179. DOI: 10.1128/JCM.43.12.5992-5995.2005. View

3.
Maraha B, van Halteren J, Verzijl J, Wintermans R, Buiting A . Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin. Clin Microbiol Infect. 2002; 8(10):671-5. DOI: 10.1046/j.1469-0691.2002.00404.x. View

4.
Silvestri L, Milanese M, Oblach L, Fontana F, Gregori D, Guerra R . Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control. 2002; 30(7):391-9. DOI: 10.1067/mic.2002.122255. View

5.
Ray A, Pultz N, Bhalla A, Aron D, Donskey C . Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients. Clin Infect Dis. 2003; 37(7):875-81. DOI: 10.1086/377451. View